Clevidipine in the Postoperative Treatment of Hypertension (ECLIPSE-NIC)
Completed · Phase 3
Conditions studied: Hypertension
In brief
The purpose of this study is to establish the safety of clevidipine in the treatment of postoperative hypertension. Approximately 250-500 patients with postoperative hypertension after undergoing coronary artery bypass grafting (CABG), off-pump coronary artery bypass (OPCAB) or minimally invasive direct coronary artery bypass (MIDCAB) surgery and/or valve replacement/repair procedures were anticipated to be randomly assigned to one of two treatment groups: clevidipine or nicardipine.
Key facts
- Study ID
- NCT00093925
- Run by
- The Medicines Company
- People needed
- 739
- Starts
- 2004-05-01
- Expected to finish
- 2006-09-01
- Last updated by the study team
- 2014-05-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mobile Infirmary Medical Center — Mobile, Alabama, United States
- Wesley Medical Center — Wichita, Kansas, United States
- Touro Infirmary — New Orleans, Louisiana, United States
- Ochsner Clinic Foundation — New Orleans, Louisiana, United States
- Columbia University - College of Physicians and Surgeons — New York, New York, United States
- Jack D. Weller Hospital — The Bronx, New York, United States
- Montefiore Medical Center — The Bronx, New York, United States
- Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania, United States
- VA Medical Center McGuire — Richmond, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.